|
Name |
2-hydroxy-6-(hydroxymethyl)-8-methoxy-9-oxo-xanthene-1-carboxylic Acid
|
| Molecular Formula | C16H12O7 | |
| IUPAC Name* |
2-hydroxy-6-(hydroxymethyl)-8-methoxy-9-oxoxanthene-1-carboxylic acid
|
|
| SMILES |
COC1=CC(=CC2=C1C(=O)C3=C(O2)C=CC(=C3C(=O)O)O)CO
|
|
| InChI |
InChI=1S/C16H12O7/c1-22-10-4-7(6-17)5-11-13(10)15(19)14-9(23-11)3-2-8(18)12(14)16(20)21/h2-5,17-18H,6H2,1H3,(H,20,21)
|
|
| InChIKey |
WKVDGQDBUCFWBJ-UHFFFAOYSA-N
|
|
| Synonyms |
CHEMBL590883; 2-hydroxy-6-(hydroxymethyl)-8-methoxy-9-oxo-9H-xanthene-1-carboxylic acid; BDBM50339595; 2-hydroxy-6-(hydroxymethyl)-8-methoxy-9-oxo-xanthene-1-carboxylic Acid; 2-hydroxy-6-hydroxymethyl-8-methoxy-9-oxo-9h-xanthene-1-carboxylic acid
|
|
| CAS | NA | |
| PubChem CID | 11278507 | |
| ChEMBL ID | CHEMBL590883 |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 316.26 | ALogp: | 1.8 |
| HBD: | 3 | HBA: | 7 |
| Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 113.0 | Aromatic Rings: | 3 |
| Heavy Atoms: | 23 | QED Weighted: | 0.635 |
| Caco-2 Permeability: | -5.259 | MDCK Permeability: | 0.00001890 |
| Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.975 |
| Human Intestinal Absorption (HIA): | 0.56 | 20% Bioavailability (F20%): | 0.04 |
| 30% Bioavailability (F30%): | 0.99 |
| Blood-Brain-Barrier Penetration (BBB): | 0.236 | Plasma Protein Binding (PPB): | 82.54% |
| Volume Distribution (VD): | 1.213 | Fu: | 15.26% |
| CYP1A2-inhibitor: | 0.349 | CYP1A2-substrate: | 0.848 |
| CYP2C19-inhibitor: | 0.025 | CYP2C19-substrate: | 0.089 |
| CYP2C9-inhibitor: | 0.057 | CYP2C9-substrate: | 0.696 |
| CYP2D6-inhibitor: | 0.096 | CYP2D6-substrate: | 0.171 |
| CYP3A4-inhibitor: | 0.111 | CYP3A4-substrate: | 0.07 |
| Clearance (CL): | 3.646 | Half-life (T1/2): | 0.857 |
| hERG Blockers: | 0.01 | Human Hepatotoxicity (H-HT): | 0.103 |
| Drug-inuced Liver Injury (DILI): | 0.511 | AMES Toxicity: | 0.421 |
| Rat Oral Acute Toxicity: | 0.008 | Maximum Recommended Daily Dose: | 0.76 |
| Skin Sensitization: | 0.386 | Carcinogencity: | 0.35 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.699 |
| Respiratory Toxicity: | 0.895 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002148 | ![]() |
0.783 | D06GCK | ![]() |
0.347 | ||
| ENC002668 | ![]() |
0.726 | D0K8KX | ![]() |
0.337 | ||
| ENC004289 | ![]() |
0.597 | D04AIT | ![]() |
0.330 | ||
| ENC002469 | ![]() |
0.590 | D0G5UB | ![]() |
0.323 | ||
| ENC001749 | ![]() |
0.577 | D07MGA | ![]() |
0.319 | ||
| ENC002690 | ![]() |
0.556 | D0QD1G | ![]() |
0.313 | ||
| ENC003785 | ![]() |
0.518 | D0G7IY | ![]() |
0.306 | ||
| ENC002404 | ![]() |
0.518 | D06NSS | ![]() |
0.306 | ||
| ENC004886 | ![]() |
0.513 | D0Z3DY | ![]() |
0.278 | ||
| ENC002284 | ![]() |
0.513 | D0S6JG | ![]() |
0.276 | ||